Biotech

All Articles

Former Seagen CEO unveils new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer last year for an ...

Ironwood creates more purpose $1B GI medicine with brand new subgroup data

.On the heels of a phase 3 win that stopped working to excite financiers, Ironwood Pharmaceuticals i...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not quit Monte Rosa Rehabs currently. The Boston-based biotech is enjoying after signing a take ...

Jade carves out exec team along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Septerna goes social with upsized offering of $288M

.Commemorating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey F...

AbbVie brings in Richter wealthier, paying $25M to constitute finding pact

.AbbVie has actually come back to the source of its own antipsychotic giant Vraylar in search of an ...

GenSight enters ultimate full weeks of money runway as revenue stream slips by of scope

.GenSight Biologics is full weeks away from running out of amount of money. Again. The biotech simpl...

AZ licenses discarded unusual disease medication to Monopar Therapeutics

.Monopar Therapeutics is actually recovering a drug coming from the dump of AstraZeneca's rare ailme...

Arcus' brand-new HIF-2a records in kidney cancer hint at potential upper hand over Merck's Welireg, analysts point out

.With new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of experts ...

Roche wagers approximately $1B to expand Dyno genetics therapy delivery pact

.After forming a genetics treatment alliance with Dyno Rehabs in 2020, Roche is back for additional....